share_log

This Health Catalyst Insider Increased Their Holding By 42% Last Year

This Health Catalyst Insider Increased Their Holding By 42% Last Year

這位 Health Catalyst 內部人士去年將其持股量增加了 42%
Simply Wall St ·  2023/09/16 08:03

From what we can see, insiders were net buyers in Health Catalyst, Inc.'s (NASDAQ:HCAT ) during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it.

從我們可以看到,內部人士是淨買家在健康催化劑公司S(納斯達克:HCAT)在過去12個月中。也就是說,內部人士購買股票的數量超過了他們出售股票的數量。

While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

儘管就長期投資而言,內幕交易並不是最重要的事情,但從邏輯上講,你應該關注內部人士是在買入還是賣出股票。

Check out our latest analysis for Health Catalyst

查看我們對Health Catalyst的最新分析

The Last 12 Months Of Insider Transactions At Health Catalyst

Health Catalyst最近12個月的內幕交易

Over the last year, we can see that the biggest insider purchase was by CEO & Director Daniel Burton for US$2.0m worth of shares, at about US$10.14 per share. That means that an insider was happy to buy shares at around the current price of US$10.41. That means they have been optimistic about the company in the past, though they may have changed their mind. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. The good news for Health Catalyst share holders is that an insider was buying at near the current price. Daniel Burton was the only individual insider to buy shares in the last twelve months.

在過去的一年裡,我們可以看到最大的內部人購買是首席執行官Daniel·伯頓以每股10.14美元的價格購買了價值200萬美元的股票。這意味著一位內部人士樂於以目前10.41美元的價格買入股票。這意味著他們過去一直對該公司持樂觀態度,儘管他們可能改變了主意。如果有人以遠低於當前價格的價格買入股票,總的來說這是一個好兆頭,但要記住,他們可能不再看到價值。對於Health Catalyst的股東來說,好消息是一位內部人士以接近當前價格的價格買入。Daniel·伯頓是過去12個月中唯一買入股票的個人內部人士。

Daniel Burton purchased 246.13k shares over the year. The average price per share was US$10.15. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

Daniel·伯頓在一年中購買了246.13萬股。每股均價為10.15美元。下面的圖表顯示了過去一年的內幕交易(按公司和個人)。如果你想知道到底是誰賣了,賣了多少錢,什麼時候賣的,只需點擊下面的圖表!

insider-trading-volume
NasdaqGS:HCAT Insider Trading Volume September 16th 2023
NasdaqGS:HCAT內幕交易量2023年9月16日

Health Catalyst is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Health Catalyst並不是業內人士唯一買入的股票。對於那些想要找到贏得投資免費最近有內幕收購的不斷增長的公司名單可能就是合適的選擇。

Insider Ownership Of Health Catalyst

Health Catalyst的內部人所有權

For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 2.6% of Health Catalyst shares, worth about US$16m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

對於一個普通股股東來說,公司內部人士持有多少股份值得一查。我認為,如果內部人士持有該公司大量股份,這是一個好兆頭。內部人士擁有Health Catalyst 2.6%的股份,價值約1600萬美元。雖然這是一個強大但並不突出的內部人持股水準,但這足以表明管理層和小股東之間的某種一致性。

So What Do The Health Catalyst Insider Transactions Indicate?

那麼,Health Catalyst Insider的交易表明了什麼?

There haven't been any insider transactions in the last three months -- that doesn't mean much. However, our analysis of transactions over the last year is heartening. Insiders do have a stake in Health Catalyst and their transactions don't cause us concern. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. In terms of investment risks, we've identified 2 warning signs with Health Catalyst and understanding them should be part of your investment process.

過去三個月沒有發生任何內幕交易--這並不意味著什麼。然而,我們對過去一年交易的分析令人振奮。內部人士確實持有Health Catalyst的股份,他們的交易不會引起我們的擔憂。因此,雖然瞭解內部人士在買入或賣出方面做了什麼是有幫助的,但瞭解一家特定公司面臨的風險也是有幫助的。在投資風險方面,我們已經確定了兩個警告信號使用Health Catalyst並瞭解它們應該是您投資過程的一部分。

Of course Health Catalyst may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然了Health Catalyst可能不是最值得購買的股票那就是。所以你可能想看看這個免費匯集了高質量的公司.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前只處理公開市場交易和私下處置直接權益,而不處理衍生工具交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論